How Kalleid Helped an AI-Driven Drug Discovery Startup Meet IT Policy and Internal Control Compliance
In an era when artificial intelligence (AI) could revolutionize the healthcare industry, a dynamic startup, harnessing AI to identify clinical candidates with therapeutic needs, found itself on the fast track to growth. With rapid expansion the startup needed to align its IT policy with widely adopted NIST SP500-53 requirements and internal control standards, as defined by the Committee of Sponsoring Organizations (COSO) framework. Recognizing these challenges, the startup turned to Kalleid, known for its expertise in supporting life sciences and pharmaceutical companies through similar compliance landscapes.
